The Research Center for Clinical Neuroimmunology and Neuroscience Basel is an interdisciplinary research institution supported by a non-profit foundation.
Joined February 2022
- Tweets 123
- Following 80
- Followers 143
- Likes 216
63 Photos and videos
RC2NB retweeted
Apr 12
Yesđź‘Ť from @SofiaSandgren1 @JensKuhle @RC2NB @UniBasel: Blood NfL can provide information on disease activity, prognosis and treatment response, both in drug development trials and in personalised medicine in #MultipleSclerosis.
đź”˝
journals.sagepub.com/doi/abs…
2/🧵
1
2
4
267
RC2NB retweeted
John Dystel Prize for Multiple Sclerosis Research awarded to Dr. Ludwig Kappos for his transformative contributions to MS research
eurekalert.org/news-releases…
3
13
636
Our latest Annual Report is out 🚀
Full of insights, milestones, and momentum through research, data innovation, and collaboration.
👉 Get it here: rc2nb.ch/media-and-downloads…
1
23
RC2NB retweeted
Feb 3
In #MultipleSclerosis, treatment effects on blood neurofilament light chain #NfL are moderately associated with therapeutic effects on relapses and MRI lesions.
A meta-regression of randomized controlled trials from @RC2NB @UniBasel_en @unige_en ▶️ journals.sagepub.com/doi/abs…
6
8
525
RC2NB retweeted
Mar 3
OCT availability and routine use by neurologists is limited in Switzerland. Awareness, education and guidelines on its clinical use in the care of people with #MultipleSclerosis.
🔓MSJ-ETC study from @Unispital_USZ @RC2NB ▶️ journals.sagepub.com/doi/ful…
1
9
466
RC2NB retweeted
Mar 12
Deep learning can automate the classification of paramagnetic rim and remyelinated lesions in #MultipleSclerosis, guiding personalized treatment decisions.
Study from @CristinaGranzi2 @RC2NB ▶️ journals.sagepub.com/doi/abs…
1
2
275
🎉 Congratulations to Prof. @JensKuhle , Head of the MS Centre @usb_ch and Group Leader @RC2NB, for being named one of Clarivate’s Highly Cited Researchers 2025, ranking among the top 1% most cited scientists worldwide.
#HighlyCited2025 #ResearchExcellence #Neuroscience
1
1
53
RC2NB retweeted
22 Oct 2025
New study in Science Translational Medicine (@ScienceMagazine) from @akproebstel and colleagues reveals distinct immune signatures in MOG antibody–associated disease (MOGAD), distinguishing it from MS. Researchers from Zurich, Munich, Toulouse, Lyon, Bonn & Basel (@DepBiomedicine, @DKFBasel, @RC2NB) uncover key immune differences shaping future therapies.
👉🏻 Link: science.org/doi/10.1126/scit…
#MOGAD #MSResearch #Neuroinflammation
ALT Visual representation of neuroinflammation: red, reactive immune activity disrupting the normal blue neural network. The image symbolizes the immune dysregulation underlying MOG antibody–associated disease (MOGAD). Image Adobe Stock.
1
2
201
New study led by David Leppert, Roberto Furlan & @JensKuhle shows that specific CSF markers can distinguish MOGAD & NMOSD from MS.
A fast, biology-driven approach for accurate diagnosis in acute demyelination.
academic.oup.com/brain/advan…
#MS #MOGAD #NMOSD #Biomarkers
1
1
53
🧪 New data from the phase 3 POINT study: combining ponesimod dimethyl fumarate in relapsing MS did not improve relapse rate, but reduced MRI lesion activity vs DMF alone. Safety was consistent with known profiles.
📄 sciencedirect.com/science/ar…
2
77
RC2NB retweeted
23 Jun 2025
MSIF is proud to announce Professor Ludwig Kappos as the 2025 #CharcotAward recipient, honouring a lifetime of impact in #MSResearch. 🏆🔬
From pioneering treatments to mentoring researchers worldwide, his legacy is global. 🌎
Read more: msintfederation.org/4ncra5K
Â
@RC2NB
1
8
33
1,916
🚀 Our new website is live!
Explore RC2NB's research, people & purpose — now at RC2NB.ch 🧠✨
🎬 Watch the RC2NB Welcome Video for a glimpse into our world.
▶️ vimeo.com/1090750659/1325893…
#RC2NB #Neuroimmunology #MSResearch #WebsiteLaunch
1
3
71
RC2NB retweeted
24 May 2025
Functional System scores and their corresponding subscores, Ambulation scores and EDSS scores revealed different patterns of disability in #MultipleSclerosis.
Machine learning study using EXPAND trial from @RC2NB @UniBasel_en @UniSpitalBasel ▶️ journals.sagepub.com/doi/ful…
2
9
415
🧠New in Neurol Neuroimmunol Neuroinflamm:
CSF TNF markers early gray matter damage predict PIRA in early RRMS.
Key predictors: sTNFR1, sTNFR2, LIGHT, cortical lesions, thalamic atrophy.
🔗pubmed.ncbi.nlm.nih.gov/4031…
#MS #PIRA #Neuroinflammation #MRI #CSF #MultipleSclerosis
2
64
RC2NB retweeted
15 Apr 2025
Just 24 participants to go:
Our Swisswide pragmatic #MultiSCRIPT trial is close to reaching 915 in about a year.
Only possible through full embedding in routine care and with an outstanding team @RC2NB and #SMC and the wonderful support of our patients.
multiscript.rc2nb.ch/
2
8
196
In RC2NB’s Annual Report, real patient stories highlight why personalized treatments & cutting-edge research matter. Together, we’re shaping the future of MS care. #MS #Research #PatientVoices
1
2
71
We are pleased to present the @RC2NB Annual Report 2024, highlighting a year of progress, key milestones, and scientific advancements across our four core workstreams. 📖 Read the full report here: rc2nb.ch/wp-content/uploads/…
2
3
117
Feb 11 – International Day of Women & Girls in Science! 🚀 At #RC2NB & @ThINk_Basel , this day is every day. Leading the way? Prof. Cristina Granziera, championing brilliant women who shape the future of #STEM.🔬💡 #WomenInScience #IDWGS #MSresearch
2
70
@RC2NB joined the MS State of the Art Symposium 2025 on "Lifestyle in MS: Sports, Nutrition, & Brain Health."
Proud to see @ThINk_Basel & @JensKuhle represent RC2NB, with our team sharing research on:
🔬 MultiSCRIPT
🔬 Complement activation in MS
🔬 B cell therapies
1
2
76